Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 721

1.

Adult-Onset Still's Disease and Macrophage-Activating Syndrome Progressing to Lymphoma: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery.

Mehta B, Kasturi S, Teruya-Feldstein J, Horwitz S, Bass AR, Erkan D.

HSS J. 2018 Jul;14(2):214-221. doi: 10.1007/s11420-018-9606-8. Epub 2018 Mar 26. No abstract available.

PMID:
29983666
2.

Does an Autism Spectrum Disorder Care Pathway Improve Care for Children and Adolescents with ASD in Inpatient Psychiatric Units?

Kuriakose S, Filton B, Marr M, Okparaeke E, Cervantes P, Siegel M, Horwitz S, Havens J.

J Autism Dev Disord. 2018 Jul 3. doi: 10.1007/s10803-018-3666-y. [Epub ahead of print]

PMID:
29971653
3.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2018 Jun 26. doi: 10.1093/annonc/mdy207. [Epub ahead of print] No abstract available.

PMID:
29947731
4.

Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.

Intlekofer AM, Joffe E, Batlevi CL, Hilden P, He J, Seshan VE, Zelenetz AD, Palomba ML, Moskowitz CH, Portlock C, Straus DJ, Noy A, Horwitz SM, Gerecitano JF, Moskowitz A, Hamlin P, Matasar MJ, Kumar A, van den Brink MR, Knapp KM, Pichardo JD, Nahas MK, Trabucco SE, Mughal T, Copeland AR, Papaemmanuil E, Moarii M, Levine RL, Dogan A, Miller VA, Younes A.

Blood Cancer J. 2018 Jun 12;8(6):60. doi: 10.1038/s41408-018-0089-0.

5.

Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile.

Querfeld C, Leung S, Myskowski PL, Curran SA, Goldman DA, Heller G, Wu X, Kil SH, Sharma S, Finn KJ, Horwitz S, Moskowitz A, Mehrara B, Rosen ST, Halpern AC, Young JW.

Cancer Immunol Res. 2018 Jun 12. pii: canimm.0270.2017. doi: 10.1158/2326-6066.CIR-17-0270. [Epub ahead of print]

PMID:
29895574
6.

TCR-δ Expression and γδ+ T-cell Infiltrates in Primary Cutaneous Gamma-delta T-cell Lymphoma and other Cutaneous T-cell Lymphoproliferative Disorders.

Pulitzer M, Geller S, Kumar E, Frosina D, Moskowitz A, Horwitz S, Myskowski P, Kheterpal M, Chan A, Dogan A, Jungbluth A.

Histopathology. 2018 Jun 12. doi: 10.1111/his.13671. [Epub ahead of print]

PMID:
29893430
7.

Decreased functional connectivity in the fronto-parietal network in children with mood disorders compared to children with dyslexia during rest: An fMRI study.

Horowitz-Kraus T, Woodburn M, Rajagopal A, Versace AL, Kowatch RA, Bertocci MA, Bebko G, Almeida JRC, Perlman SB, Travis MJ, Gill MK, Bonar L, Schirda C, Diwadkar VA, Sunshine JL, Birmaher B, Axelson D, Gerry Taylor H, Horwitz SM, Frazier T, Eugene Arnold L, Fristad MA, Youngstrom EA, Findling RL, Phillips ML, Holland SK.

Neuroimage Clin. 2018 Mar 1;18:582-590. doi: 10.1016/j.nicl.2018.02.034. eCollection 2018.

8.

Diffusion imaging markers of bipolar versus general psychopathology risk in youth at-risk.

Versace A, Ladouceur CD, Graur S, Acuff HE, Bonar LK, Monk K, McCaffrey A, Yendiki A, Leemans A, Travis MJ, Diwadkar VA, Holland SK, Sunshine JL, Kowatch RA, Horwitz SM, Frazier TW, Arnold LE, Fristad MA, Youngstrom EA, Findling RL, Goldstein BI, Goldstein T, Axelson D, Birmaher B, Phillips ML.

Neuropsychopharmacology. 2018 May 4. doi: 10.1038/s41386-018-0083-z. [Epub ahead of print]

PMID:
29795244
9.

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.

Ng SY, Yoshida N, Christie AL, Ghandi M, Dharia NV, Dempster J, Murakami M, Shigemori K, Morrow SN, Van Scoyk A, Cordero NA, Stevenson KE, Puligandla M, Haas B, Lo C, Meyers R, Gao G, Cherniack A, Louissaint A Jr, Nardi V, Thorner AR, Long H, Qiu X, Morgan EA, Dorfman DM, Fiore D, Jang J, Epstein AL, Dogan A, Zhang Y, Horwitz SM, Jacobsen ED, Santiago S, Ren JG, Guerlavais V, Annis DA, Aivado M, Saleh MN, Mehta A, Tsherniak A, Root D, Vazquez F, Hahn WC, Inghirami G, Aster JC, Weinstock DM, Koch R.

Nat Commun. 2018 May 22;9(1):2024. doi: 10.1038/s41467-018-04356-9.

10.

Treatment of Vulvar Mycosis Fungoides Tumors With Localized Radiotherapy.

Geller S, Pitter K, Moskowitz A, Horwitz SM, Yahalom J, Myskowski PL.

Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e279-e281. doi: 10.1016/j.clml.2018.04.010. Epub 2018 May 4. No abstract available.

PMID:
29752211
11.

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.

Federico M, Bellei M, Marcheselli L, Schwartz M, Manni M, Tarantino V, Pileri S, Ko YH, Cabrera ME, Horwitz S, Kim WS, Shustov A, Foss FM, Nagler A, Carson K, Pinter-Brown LC, Montoto S, Spina M, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Gabus R, Vose JM, Advani RH; T cell Project Network.

Br J Haematol. 2018 Jun;181(6):760-769. doi: 10.1111/bjh.15258. Epub 2018 Apr 19.

12.

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma.

Kumar A, Vardhana S, Moskowitz AJ, Porcu P, Dogan A, Dubovsky JA, Matasar MJ, Zhang Z, Younes A, Horwitz SM.

Blood Adv. 2018 Apr 24;2(8):871-876. doi: 10.1182/bloodadvances.2017011916.

13.

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project.

Bellei M, Foss FM, Shustov AR, Horwitz SM, Marcheselli L, Kim WS, Cabrera ME, Dlouhy I, Nagler A, Advani RH, Pesce EA, Ko YH, Martinez V, Montoto S, Chiattone C, Moskowitz A, Spina M, Biasoli I, Manni M, Federico M; International T-cell Project Network.

Haematologica. 2018 Jul;103(7):1191-1197. doi: 10.3324/haematol.2017.186577. Epub 2018 Mar 29.

14.

Evaluation of a Train-The-Trainers Model for Family Peer Advocates in Children's Mental Health.

Hoagwood KE, Olin SS, Storfer-Isser A, Kuppinger A, Shorter P, Wang NM, Pollock M, Peth-Pierce R, Horwitz S.

J Child Fam Stud. 2018;27(4):1130-1136. doi: 10.1007/s10826-017-0961-8. Epub 2017 Dec 1.

15.

Improved Dose-Response Relationship of (+)-Discodermolide-Taxol Hybrid Congeners.

Nadaradjane C, Yang CH, Rodriguez-Gabin A, Ye K, Sugasawa K, Atasoylu O, Smith AB 3rd, Horwitz SB, McDaid HM.

J Nat Prod. 2018 Mar 23;81(3):607-615. doi: 10.1021/acs.jnatprod.8b00111. Epub 2018 Mar 9.

16.

Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.

Yang CH, Wang C, Ojima I, Horwitz SB.

J Nat Prod. 2018 Mar 23;81(3):600-606. doi: 10.1021/acs.jnatprod.7b01047. Epub 2018 Mar 8.

PMID:
29517223
17.

Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas.

Fanale MA, Horwitz SM, Forero-Torres A, Bartlett NL, Advani RH, Pro B, Chen RW, Davies A, Illidge T, Uttarwar M, Lee SY, Ren H, Kennedy DA, Shustov AR.

Blood. 2018 May 10;131(19):2120-2124. doi: 10.1182/blood-2017-12-821009. Epub 2018 Mar 5.

18.

Differences in Medicaid Antipsychotic Medication Measures Among Children with SSI, Foster Care, and Income-Based Aid.

Leckman-Westin E, Finnerty M, Scholle SH, Pritam R, Layman D, Kealey E, Byron S, Morden E, Bilder S, Neese-Todd S, Horwitz S, Hoagwood K, Crystal S.

J Manag Care Spec Pharm. 2018 Mar;24(3):238-246. doi: 10.18553/jmcp.2018.24.3.238.

19.

NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.

Horwitz SM, Ansell SM, Ai WZ, Barnes J, Barta SK, Choi M, Clemens MW, Dogan A, Greer JP, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Kim YH, Lunning MA, Mehta A, Mehta-Shah N, Oki Y, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shustov A, Sokol L, Torka P, Wilcox R, William B, Zain J, Dwyer MA, Sundar H.

J Natl Compr Canc Netw. 2018 Feb;16(2):123-135. doi: 10.6004/jnccn.2018.0007.

PMID:
29439173
20.

Friendly Faces: Characteristics of Children and Adolescents With Repeat Visits to a Specialized Child Psychiatric Emergency Program.

Marr M, Horwitz SM, Gerson R, Storfer-Isser A, Havens JF.

Pediatr Emerg Care. 2018 Feb 12. doi: 10.1097/PEC.0000000000001428. [Epub ahead of print]

PMID:
29438124
21.

Diagnostic Accuracy of the CASI-4R Psychosis Subscale for Children Evaluated in Pediatric Outpatient Clinics.

Rizvi SH, Salcedo S, Youngstrom EA, Freeman LK, Gadow KD, Fristad MA, Birmaher B, Kowatch RA, Horwitz SM, Frazier TW, Arnold LE, Taylor HG, Findling RL.

J Clin Child Adolesc Psychol. 2018 Jan 26:1-12. doi: 10.1080/15374416.2017.1410824. [Epub ahead of print]

PMID:
29373050
22.

Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.

Lahoud OB, Moskowitz AJ, Horwitz SM, Giralt SA, Dahi PB.

Bone Marrow Transplant. 2018 May;53(5):654-656. doi: 10.1038/s41409-017-0086-0. Epub 2018 Jan 22. No abstract available.

PMID:
29358601
23.

Association of Breast Implants With Anaplastic Large-Cell Lymphoma.

McCarthy CM, Horwitz SM.

JAMA Oncol. 2018 Mar 1;4(3):341-342. doi: 10.1001/jamaoncol.2017.4467. No abstract available.

PMID:
29302678
24.

Trends in Children's Mental Health Services Research Funding by the National Institute of Mental Health From 2005 to 2015: A 42% Reduction.

Hoagwood KE, Atkins M, Kelleher K, Peth-Pierce R, Olin S, Burns B, Landsverk J, Horwitz SM.

J Am Acad Child Adolesc Psychiatry. 2018 Jan;57(1):10-13. doi: 10.1016/j.jaac.2017.09.433. No abstract available.

PMID:
29301659
25.

Expression of βV-Tubulin in Secretory Cells of the Fallopian Tube Epithelium Marks Cellular Atypia.

Mathew D, Wang Y, Van Arsdale A, Horwitz SB, McDaid H.

Int J Gynecol Cancer. 2018 Feb;28(2):363-370. doi: 10.1097/IGC.0000000000001160.

26.

Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.

Horwitz SM, Koch R, Porcu P, Oki Y, Moskowitz A, Perez M, Myskowski P, Officer A, Jaffe JD, Morrow SN, Allen K, Douglas M, Stern H, Sweeney J, Kelly P, Kelly V, Aster JC, Weaver D, Foss FM, Weinstock DM.

Blood. 2018 Feb 22;131(8):888-898. doi: 10.1182/blood-2017-08-802470. Epub 2017 Dec 12.

PMID:
29233821
27.

Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies.

Flinn IW, O'Brien S, Kahl B, Patel M, Oki Y, Foss FF, Porcu P, Jones J, Burger JA, Jain N, Kelly VM, Allen K, Douglas M, Sweeney J, Kelly P, Horwitz S.

Blood. 2018 Feb 22;131(8):877-887. doi: 10.1182/blood-2017-05-786566. Epub 2017 Nov 30.

PMID:
29191916
28.

Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study.

Warren S, Kheterpal M, Myskowski PL, Moskowitz A, Horwitz SM, Pulitzer MP.

J Am Acad Dermatol. 2018 Mar;78(3):530-539. doi: 10.1016/j.jaad.2017.09.015. Epub 2017 Nov 10.

PMID:
29132694
29.

A Response to Proposed Budget Cuts Affecting Children's Mental Health: Protecting Policies and Programs That Promote Collective Efficacy.

Hoagwood KE, Atkins M, Horwitz S, Kutash K, Olin SS, Burns B, Peth-Pierce R, Kuppinger A, Burton G, Shorter P, Kelleher KJ.

Psychiatr Serv. 2018 Mar 1;69(3):268-273. doi: 10.1176/appi.ps.201700126. Epub 2017 Nov 1.

PMID:
29089015
30.

The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: are we there yet?

Geller S, Myskowski PL, Kim YH, Moskowitz A, Horwitz S.

Br J Dermatol. 2018 Feb;178(2):571. doi: 10.1111/bjd.16052. Epub 2017 Dec 18. No abstract available.

PMID:
29023638
31.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y.

Ann Oncol. 2017 Oct 1;28(10):2517-2525. doi: 10.1093/annonc/mdx352.

PMID:
28961843
32.

Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial.

Foss F, Horwitz S, Pro B, Miles Prince H, Sokol L, Balser B, Wolfson J, Coiffier B.

J Hematol Oncol. 2017 Sep 18;10(1):154. doi: 10.1186/s13045-017-0518-8. No abstract available.

33.

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.

Moskowitz AJ, Schöder H, Gavane S, Thoren KL, Fleisher M, Yahalom J, McCall SJ, Cadzin BR, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz SM, Kumar A, Matasar M, Ni A, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Straus D, Younes A, Zelenetz AD, Moskowitz CH.

Blood. 2017 Nov 16;130(20):2196-2203. doi: 10.1182/blood-2017-06-788877. Epub 2017 Sep 5.

PMID:
28874350
34.

Clinical Outcome and Prognosis of Young Patients with Mycosis Fungoides.

Virmani P, Levin L, Myskowski PL, Flores E, Marchetti MA, Lucas AS, Pulitzer M, Horwitz S, Trippett T, Moskowitz A, Querfeld C.

Pediatr Dermatol. 2017 Sep;34(5):547-553. doi: 10.1111/pde.13226. Epub 2017 Aug 14.

PMID:
28804919
35.

Adult T-Cell Leukemia/Lymphoma.

Mehta-Shah N, Ratner L, Horwitz SM.

J Oncol Pract. 2017 Aug;13(8):487-492. doi: 10.1200/JOP.2017.021907. Review.

PMID:
28796966
36.

Taxol®: The First Microtubule Stabilizing Agent.

Yang CH, Horwitz SB.

Int J Mol Sci. 2017 Aug 9;18(8). pii: E1733. doi: 10.3390/ijms18081733. Review.

37.

Developing a sustainable child and family service system after a community tragedy: Lessons from Sandy Hook.

Hoagwood KE, Olin SS, Wang NM, Pollock M, Acri M, Glaeser E, Whitmyre ED, Storfer-Isser A, Horwitz SM.

J Community Psychol. 2017 Aug;45(6):748-764. doi: 10.1002/jcop.21890. Epub 2017 Apr 21.

38.

Reading related white matter structures in adolescents are influenced more by dysregulation of emotion than behavior.

Horowitz-Kraus T, Holland SK, Versace AL, Bertocci MA, Bebko G, Almeida JRC, Perlman SB, Travis MJ, Gill MK, Bonar L, Schirda C, Sunshine JL, Birmaher B, Taylor G, Diwadkar VA, Horwitz SM, Axelson D, Frazier T, Arnold EL, Fristad MA, Youngstrom EA, Findling RL, Phillips ML.

Neuroimage Clin. 2017 Jun 23;15:732-740. doi: 10.1016/j.nicl.2017.06.020. eCollection 2017.

39.

Using machine learning and surface reconstruction to accurately differentiate different trajectories of mood and energy dysregulation in youth.

Versace A, Sharma V, Bertocci MA, Bebko G, Iyengar S, Dwojak A, Bonar L, Perlman SB, Schirda C, Travis M, Gill MK, Diwadkar VA, Sunshine JL, Holland SK, Kowatch RA, Birmaher B, Axelson D, Frazier TW, Arnold LE, Fristad MA, Youngstrom EA, Horwitz SM, Findling RL, Phillips ML.

PLoS One. 2017 Jul 6;12(7):e0180221. doi: 10.1371/journal.pone.0180221. eCollection 2017.

40.

Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab.

Virmani P, Busam K, Myskowski PL, Yang A, Magro C, Horwitz S.

JAAD Case Rep. 2017 Jun 14;3(4):269-272. doi: 10.1016/j.jdcr.2017.02.024. eCollection 2017 Jul. No abstract available.

41.

Utilization Patterns at a Specialized Children's Comprehensive Psychiatric Emergency Program.

Gerson R, Havens J, Marr M, Storfer-Isser A, Lee M, Rojas Marcos C, Liu M, Horwitz SM.

Psychiatr Serv. 2017 Nov 1;68(11):1104-1111. doi: 10.1176/appi.ps.201600436. Epub 2017 Jun 15.

PMID:
28617206
42.

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.

Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, Kuzel TM, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin HM, Liu Y, Huebner D, Little M, Whittaker S, Duvic M; ALCANZA study group.

Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7.

PMID:
28600132
43.

Highlights in lymphoma from the 2016 American Society of Hematology annual meeting and exposition: Commentary.

Horwitz SM.

Clin Adv Hematol Oncol. 2017 Feb;15 Suppl 1(2):20-23. No abstract available.

PMID:
28590460
44.

Longitudinal relationships among activity in attention redirection neural circuitry and symptom severity in youth.

Bertocci MA, Bebko G, Dwojak A, Iyengar S, Ladouceur CD, Fournier JC, Versace A, Perlman SB, Almeida JRC, Travis MJ, Gill MK, Bonar L, Schirda C, Diwadkar VA, Sunshine JL, Holland SK, Kowatch RA, Birmaher B, Axelson D, Horwitz SM, Frazier T, Arnold LE, Fristad MA, Youngstrom EA, Findling RL, Phillips ML.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 May;2(4):336-345. doi: 10.1016/j.bpsc.2016.06.009.

45.

Beyond Screening: A Stepped Care Pathway for Managing Postpartum Depression in Pediatric Settings.

Olin SS, McCord M, Stein REK, Kerker BD, Weiss D, Hoagwood KE, Horwitz SM.

J Womens Health (Larchmt). 2017 Sep;26(9):966-975. doi: 10.1089/jwh.2016.6089. Epub 2017 Apr 14.

PMID:
28409703
46.

Longitudinal course and characteristics of cyclothymic disorder in youth.

Van Meter AR, Youngstrom EA, Birmaher B, Fristad MA, Horwitz SM, Frazier TW, Arnold LE, Findling RL.

J Affect Disord. 2017 Jun;215:314-322. doi: 10.1016/j.jad.2017.03.019. Epub 2017 Mar 14.

47.

Communication between oncologists and lymphoma survivors during follow-up consultations: A qualitative analysis.

Franco K, Shuk E, Philip E, Blanch-Hartigan D, Parker PA, Matasar M, Horwitz S, Kissane D, Banerjee SC, Bylund CL.

J Psychosoc Oncol. 2017 Sep-Oct;35(5):513-530. doi: 10.1080/07347332.2017.1313352. Epub 2017 Mar 30.

48.

Adoption of innovative and evidence-based practices for children and adolescents in state-supported mental health clinics: a qualitative study.

Palinkas LA, Um MY, Jeong CH, Chor KH, Olin S, Horwitz SM, Hoagwood KE.

Health Res Policy Syst. 2017 Mar 29;15(1):27. doi: 10.1186/s12961-017-0190-z.

49.

Uncommon Variants of T-Cell Lymphomas.

Mehta-Shah N, Horwitz S.

Hematol Oncol Clin North Am. 2017 Apr;31(2):285-295. doi: 10.1016/j.hoc.2016.11.004. Review.

PMID:
28340879
50.

The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma.

Soumerai JD, Zelenetz AD, Moskowitz CH, Palomba ML, Hamlin PA Jr, Noy A, Straus DJ, Moskowitz AJ, Younes A, Matasar MJ, Horwitz SM, Portlock CS, Konner JA, Gounder MM, Hyman DM, Voss MH, Fury MG, Gajria D, Carvajal RD, Ho AL, Beumer JH, Kiesel B, Zhang Z, Chen A, Little RF, Jarjies C, Dang TO, France F, Mishra N, Gerecitano JF.

Clin Cancer Res. 2017 Aug 1;23(15):4119-4126. doi: 10.1158/1078-0432.CCR-16-3068. Epub 2017 Mar 17.

Supplemental Content

Loading ...
Support Center